FBP1 promotes ovarian cancer development through the acceleration of cell cycle transition and metastasis

Oncology Letters
Xifeng XiongZhihe Liu

Abstract

Epithelial ovarian cancer (EOC) is the fifth most common malignancy in women, with a 5-year mortality of >70% in North America. As the symptoms are often not observed until the cancer has spread extensively, few women are diagnosed at an early stage of disease. Large-scale gene expression analyses have identified molecular subtypes within high-grade ovarian cancer with variable survival rates and drug resistance. The understanding of gene expression, the mechanisms underlying cancer processes and drug resistances have facilitated the development of targeted therapies. The far-upstream element (Fuse)-binding protein 1 (FBP1) is overexpressed in a number of malignancies such as hepatocellular carcinoma, and has been identified as an oncoprotein. In our early studies, FBP1 was demonstrated to physically interact with p53 and suppresses p53 transcription activity. In the present study, FBP1 expression increased as ovarian cancer developed. Among ovarian normal, adenoma and carcinoma tissues, the highest FBP1 expression was identified in carcinoma tissues. Furthermore FBP1 did not influence the apoptosis of ovarian carcinoma cells, yet enhanced cell cycle transition and metastasis. Therefore, it was hypothesized that FBP1 promotes o...Continue Reading

References

Apr 29, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A du BoisJ T Thigpen
Aug 30, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P NeijtH C van Houwelingen
Oct 2, 2001·CA: a Cancer Journal for Clinicians·R T GreenleeM Thun
Jul 2, 2003·Nature Reviews. Cancer·Roshan Agarwal, Stan B Kaye
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert F OzolsUNKNOWN Gynecologic Oncology Group
Dec 6, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J J Biagi, E A Eisenhauer
Jan 28, 2004·European Journal of Drug Metabolism and Pharmacokinetics·J Y AJ H Liu
Dec 7, 2006·Journal of the National Cancer Institute·Harvey A RischSteven A Narod
Feb 7, 2008·Nature Clinical Practice. Oncology·Patricia S Steeg, Dan Theodorescu
May 23, 2009·Nature Reviews. Cancer·Robert C BastGordon B Mills
Jul 9, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mona MalzKai Breuhahn
Jul 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Uta RabenhorstMartin Zörnig
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig ReynoldsGerold Bepler
Jul 9, 2010·Cancer Research·James E Talmadge, Isaiah J Fidler
Sep 18, 2010·Current Medicinal Chemistry·O ZitkaR Kizek
Nov 23, 2010·The FEBS Journal·Elin Hadler-OlsenJan-Olof Winberg
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Sep 6, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Weiyi GongJingcheng Dong
Jan 23, 2016·Nature·Joan Massagué, Anna C Obenauf

❮ Previous
Next ❯

Citations

Feb 8, 2020·Journal of Cellular Biochemistry·Caihua DongXia Liu
May 1, 2019·International Journal of Environmental Research and Public Health·San-Nung ChenKuan-Hao Tsui
Nov 17, 2020·Frontiers in Oncology·Florentina DuicăDragoş-Valentin Predescu
Jul 6, 2021·Computational and Mathematical Methods in Medicine·Shan GaoXuefeng Ren

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
protein assay
flow cytometry

Software Mentioned

BD CellQuest Pro
SPSS
Quantity One
Image
Pro Plus

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.